RosserBSWrightMHoeferC, et al. Recruiting an underserved, difficult-to-reach population into a clinical trial: strategies from the Restore-2 Rehabilitation trial for gay and bisexual prostate cancer patients. Clin Trials2022.
2.
JeromeLPotterKMcCarthyO, et al. A dynamic and collaborative approach to trial recruitment in Safetxt, a UK sexual health randomized controlled trial. Clin Trials. Epub ahead of print 5 March 2022. DOI: 10.1177/17407745221078882.
3.
NovotnyPJDueckACSateleD, et al. Effects of PRO order. Clin Trials2022.
4.
King-KallimanisBLBhatnagarVHorodniceanuEG, et al. Timing is everything: the importance of patient-reported outcome assessment frequency when characterizing symptomatic adverse events. Clin Trials2022.
5.
BaschEThanarajasingamGDueckAC.Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse-events (PRO-CTCAE) in cancer clinical trials. Clin Trials2022.
6.
SnyderCCrossnohereNKingM, et al. The PROTEUS-Trials Consortium: optimizing the use of patient-reported outcomes in clinical trials. Clin Trials. Epub ahead of print 31 January 2022. DOI: 10.1177/17407745221077691.
7.
Salholz-HillelMStrechDCarlisleB.Results publications are inadequately linked to trial registrations: an automated pipeline and evaluation of German university medical centers. Clin Trials. Epub ahead of print 1 April 2022. DOI: 10.1177407745221087456.
